8/20/2024 12:26:26 PM - Hit a new all-time high with today&#39;s volume-driven gain. Reported Jun &#39;24 quarterly earnings +86% on +36% sales revenues versus the year-ago period, its 2nd strong quarterly comparison. Prior 2 quarters were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>8/12/2024 12:17:10 PM - Abruptly rebounded toward its all-time high with volume-driven gains last week lifting it back above its 50 DMA line ($869). Reported Jun &#39;24 quarterly earnings +86% on +36% sales revenues versus the year-ago period, its 2nd strong quarterly comparison. Prior 2 quarters were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>7/25/2024 1:24:52 PM - Abruptly pulling back from its all-time high in recent weeks with volume-driven losses and gapped down today violating its 50 DMA line ($864). Reported Mar &#39;24 quarterly earnings +59% on +26% sales revenues versus the year-ago period. Fundamental concerns remain as the 2 prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>7/19/2024 1:14:52 PM - Abruptly pulled back from its all-time high but it is finding prompt support near its 50 DMA line ($856). Reported Mar &#39;24 quarterly earnings +59% on +26% sales revenues versus the year-ago period. Fundamental concerns remain as the 2 prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>7/18/2024 11:53:34 AM - Abruptly pulling back from its all-time high with today&#39;s big 3rd consecutive volume-driven loss violating its 50 DMA line ($855). Reported Mar &#39;24 quarterly earnings +59% on +26% sales revenues versus the year-ago period. Fundamental concerns remain as the 2 prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>7/17/2024 12:10:29 PM - Extended from any sound base and pulling back after hitting new all-time highs. Reported Mar &#39;24 quarterly earnings +59% on +26% sales revenues versus the year-ago period. Fundamental concerns remain as the 2 prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>7/3/2024 12:41:50 PM - Encountering distributional pressure after hitting new all-time highs with recent gains lacking great volume conviction. Reported Mar &#39;24 quarterly earnings +59% on +26% sales revenues versus the year-ago period. Fundamental concerns remain as the 2 prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>7/2/2024 12:55:30 PM - Retreating today after hitting new all-time highs, wedging higher with recent gains lacking great volume conviction. Reported Mar &#39;24 quarterly earnings +59% on +26% sales revenues versus the year-ago period. Fundamental concerns remain as the 2 prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>6/11/2024 12:16:11 PM - Reversed into the red today after hitting new all-time highs with a spurt of gains since clearing an orderly base. Reported Mar &#39;24 quarterly earnings +59% on +26% sales revenues versus the year-ago period. Fundamental concerns remain as the 2 prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>5/21/2024 12:09:33 PM - Gapped up today hitting a new all-time high, clearing an orderly base. Reported Mar &#39;24 quarterly earnings +59% on +26% sales revenues versus the year-ago period. Fundamental concerns remain as the 2 prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>11/2/2023 12:46:31 PM - Rebounding above its 50 DMA line ($569.58) with today&#39;s gap up gain. Reported Sep &#39;23 quarterly earnings -95% on +37% sales revenues versus the year-ago period. Fundamental concerns remain. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22.<br><hr>10/19/2023 12:33:55 PM - Retreating from its all-time high. Found prompt support in recent weeks near its 50 DMA line ($563.64). Noted with caution in prior mid-day reports - <i>"Reported Jun &#39;23 quarterly earnings +69% on +28% versus the year-ago period. Fundamental concerns remain. Prior quarterly comparisons were well below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22."</i><br><hr>10/13/2023 12:35:54 PM - Found prompt support near its 50 DMA line ($554) and rallied to new all-time highs with today&#39;s 8th consecutive volume-driven gain. Noted with caution in prior mid-day reports - <i>"Reported Jun &#39;23 quarterly earnings +69% on +28% versus the year-ago period. Fundamental concerns remain. Prior quarterly comparisons were well below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22."</i><br><hr>10/11/2023 12:42:37 PM - Found prompt support near its 50 DMA line ($547) and rebounded to hit a new all-time high with today&#39;s 6th consecutive gain. Noted with caution in prior mid-day reports - <i>"Reported Jun &#39;23 quarterly earnings +69% on +28% versus the year-ago period. Fundamental concerns remain. Prior quarterly comparisons were well below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22."</i><br><hr>10/9/2023 12:38:00 PM - Found prompt support near its 50 DMA line ($542) and rebounding toward its all-time high with today&#39;s 4th consecutiev gain. Noted with caution in prior mid-day reports - <i>"Reported Jun &#39;23 quarterly earnings +69% on +28% versus the year-ago period. Fundamental concerns remain. Prior quarterly comparisons were well below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22."</i><br><hr>9/11/2023 12:30:48 PM - Hitting another new all-time high with today&#39;s 6th consecutive gain. There was a &quot;breakaway gap&quot; on 8/08/23 for a new all-time high after it reported Jun &#39;23 quarterly earnings +69% on +28% versus the year-ago period. Fundamental concerns remain. Prior quarterly comparisons were well below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22.<br><hr>8/14/2023 12:53:07 PM - Hitting another new all-time high with today&#39;s gain. There was a "breakaway gap" on 8/08/23 for a new all-time high after it reported Jun &#39;23 quarterly earnings +69% on +28% versus the year-ago period. Fundamental concerns remain. Prior quarterly comparisons were well below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22.<br><hr>4/27/2023 1:04:53 PM - Hitting a new all-time high with today&#39;s gain. Reported Mar &#39;23 quarterly earnings -38% versus the year-ago period and fundamental concerns remain. Prior quarterly comparisons were also well below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22.<br><hr>1/20/2023 12:34:17 PM - Volume totals have been cooling while sputtering below its 50 DMA line ($362). Reported Sep &#39;22 quarterly earnings +12% on +2% sales revenues versus the year ago period. Three of the past 4 quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22.<br><hr>12/13/2022 12:53:16 PM - Reported Sep &#39;22 quarterly earnings +12% on +2% sales revenues versus the year ago period. Three of the past 4 quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Perched near its all-time high, it has made gradual progress since dropped from the Featured Stocks list on 8/11/22.<br><hr>11/14/2022 12:53:59 PM - Managed a "positive reversal" after early weakness today. Pulled back with higher volume on the prior session after touching a new all-time high last week with gains lacking great volume conviction. It made gradual progress since dropped from the Featured Stocks list on 8/11/22. Reported Sep &#39;22 quarterly earnings +12% on +2% sales revenues versus the year ago period. Three of the past 4 quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.<br><hr>11/11/2022 12:30:38 PM - Pulling back with higher volume today after touching a new all-time high on the prior session. It made gradual progress since dropped from the Featured Stocks list on 8/11/22. Reported Sep &#39;22 quarterly earnings +12% on +2% sales revenues versus the year ago period. Three of the past 4 quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.<br><hr>11/1/2022 12:54:09 PM - Pulling back today from its all-time high hit on the prior session. There was a noted gap up from below its 50 DMA line on 9/28/22. It was dropped from the Featured Stocks list on 8/11/22. Reported Sep &#39;22 quarterly earnings +12% on +2% sales revenues versus the year ago period. Three of the past 4 quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.<br><hr>10/6/2022 12:23:44 PM - Hovering near its all-time high since a noted gap up from below its 50 DMA line on 9/28/22. Dropped from the Featured Stocks list on 8/11/22. Recently reported Jun &#39;22 quarterly earnings -32% on -4% sales revenues versus the year ago period raising fundamental concerns.<br><hr>9/29/2022 12:17:40 PM - Gapped up on the prior session and hit a new all-time high, recovering from below its 50 DMA line ($314) which had acted as resistance. Dropped from the Featured Stocks list on 8/11/22. Recently reported Jun &#39;22 quarterly earnings -32% on -4% sales revenues versus the year ago period raising fundamental concerns.<br><hr>9/28/2022 12:25:15 PM - Gapped up today and hit a new all-time high, recovering from below its 50 DMA line ($314) which has acted as resistance. Dropped from the Featured Stocks list on 8/11/22. Recently reported Jun &#39;22 quarterly earnings -32% on -4% sales revenues versus the year ago period raising fundamental concerns.<br><hr>9/26/2022 12:47:10 PM - Still sputtering below its 50 DMA line ($314) which has acted as resistance. Dropped from the Featured Stocks list on 8/11/22. Recently reported Jun &#39;22 quarterly earnings -32% on -4% sales revenues versus the year ago period raising fundamental concerns.<br><hr>9/23/2022 12:49:34 PM - Still sputtering below its 50 DMA line ($314.50) which has acted as resistance. Dropped from the Featured Stocks list on 8/11/22. Recently reported Jun &#39;22 quarterly earnings -32% on -4% sales revenues versus the year ago period raising fundamental concerns.<br><hr>9/22/2022 12:35:49 PM - Sputtering below its 50 DMA line. Dropped from the Featured Stocks list on 8/11/22. Recently reported Jun &#39;22 quarterly earnings -32% on -4% sales revenues versus the year ago period raising fundamental concerns.<br><hr>8/11/2022 7:06:43 PM - Recently reported Jun '22 quarterly earnings -32% on -4% sales revenues versus the year ago period raising fundamental concerns. Sputtering since violating its 50 DMA line ($315) with noted volume-driven losses raising concerns and triggering a technical sell signal. A rebound above the 50 DMA line is needed for its outlook to improve. It will be dropped from the Featured Stocks list tonight.<br><hr>8/8/2022 12:55:42 PM - G - On track today for a 7th consecutive loss, slumping further below its 50 DMA line ($316) raising concerns. Only a prompt rebound above the 50 DMA line would help its outlook improve.<br><hr>8/4/2022 1:00:48 PM - G - Color code is changed to green while today&#39;s 5th consecutive loss is clearly violating its 50 DMA line ($316.24) raising concerns and triggering a technical sell signal. Only a prompt rebound above the 50 DMA line would help its outlook improve.<br><hr>8/3/2022 12:36:52 PM - Y - Pulling back today for a 4th consecutive loss and undercutting its 50 DMA line ($316.24) which defines important near-term support to watch. More damaging losses would raise concerns and trigger a technical sell signal.<br><hr>8/1/2022 8:08:33 PM - Y - Pulled back with light volume today and its color code is changed to yellow after pulling back below its "max buy" level. Its 50 DMA line ($315.25) defines near-term support to watch.<br><hr>7/28/2022 5:48:17 PM - G - Posted a gain with light volume today and its color code is changed to green after rising back above its "max buy" level. Its 50 DMA line ($314.10) defines near-term support to watch.<br><hr>7/27/2022 5:00:14 PM - Y - Pulled back with light volume today and its color code is changed to yellow after dipping below its "max buy" level. Its 50 DMA line ($313.47) defines near-term support to watch.<br><hr>7/25/2022 4:16:50 PM - G - Posted a 3rd consecutive quiet gain today and its color code is changed to green after inching above its "max buy" level. Its 50 DMA line ($312) defines near-term support to watch.<br><hr>7/22/2022 5:18:05 PM - Y - Posted a 2nd consecutive quiet gain today. Hovering near its "max buy" level and all-time high with light volume totals in recent weeks. Its 50 DMA line ($311) defines near-term support to watch. See the latest FSU analysis for more details and a new annotated graph.<br><hr>7/21/2022 5:09:01 PM - Y - Posted a quiet gain today. Hovering near its all-time high with light volume totals in recent weeks. Its 50 DMA line ($310) defines near-term support to watch.<br><hr>7/20/2022 6:47:07 PM - Y - Hovering near its all-time high with light volume totals in recent weeks. Its 50 DMA line ($309.42) defines near-term support to watch.<br><hr>7/19/2022 5:13:20 PM - Y - Posted a small gain today with very light volume and held its ground with light volume totals in recent weeks. Its 50 DMA line ($308.92) defines near-term support above prior lows.<br><hr>7/18/2022 5:25:57 PM - Y - Pulled back today with light volume and held its ground with light volume totals in recent weeks. Its 50 DMA line ($308.24) defines near-term support above prior lows.<br><hr>7/15/2022 5:24:54 PM - Y - Posted a gain today backed by +10% above average volume for a best ever close following a "positive reversal" on the prior session. Held its ground with light volume totals in recent weeks. Its 50 DMA line ($307.70) defines near-term support above prior lows.<br><hr>7/14/2022 4:02:10 PM - Y - Managed a "positive reversal" today while quietly consolidating, holding its ground with light volume totals in recent weeks. Its 50 DMA line ($306.85) defines near-term support above prior lows.<br><hr>7/13/2022 8:04:18 PM - Y - Quietly consolidating and holding its ground with light volume totals in recent weeks. Its 50 DMA line ($306) defines near-term support above prior lows.<br><hr>7/12/2022 7:09:21 PM - Y - Color code is changed to yellow after slumping below its "max buy" level with light volume behind today's loss. Its 50 DMA line ($305.48) defines near-term support above prior lows.<br><hr>7/11/2022 5:53:50 PM - G - Volume totals have been cooling while recently wedging up above its "max buy" level . Its 50 DMA line ($305) defines near-term support above prior lows. See the latest FSU analysis for more detailed analysis and an annotated graph.<br><hr>7/8/2022 5:30:57 PM - G - Color code is changed to green after quietly wedging up above its "max buy" level with light volume totals behind recent gains. Its 50 DMA line ($304) defines near-term support above prior lows. See the latest FSU analysis for more detailed analysis and a new annotated graph.<br><hr>7/7/2022 5:31:13 PM - Y - Color code is changed to yellow while dipping under its "max buy" level with volume totals cooling. Its 50 DMA line ($303) defines near-term support above prior lows.<br><hr>7/6/2022 5:38:40 PM - G - Color code is changed to green after rising above its "max buy" level, as volume totals have been below average while wedging further into all-time high territory with 5 consecutive gains. Its 50 DMA line ($302) defines near-term support above prior lows.<br><hr>6/30/2022 4:46:15 PM - Y - Volume totals have recently been cooling while hovering near its all-time high following 6 consecutive gains marked by higher volume. Its 50 DMA line ($300) defines near-term support above prior lows.<br><hr>6/29/2022 5:18:34 PM - Y - Volume totals have been cooling while hovering near its all-time high following 6 consecutive gains marked by higher volume. Its 50 DMA line ($299) defines near-term support above prior lows.<br><hr>6/28/2022 5:12:08 PM - Y - Retreated from its all-time high with a loss today on lighter volume following 6 consecutive gains marked by higher volume. Its 50 DMA line ($299) defines near-term support above prior lows.<br><hr>6/27/2022 5:13:41 PM - Y - Hit a new high with today's 6th consecutive gain. Rebound above the 50 DMA line ($298.47) helped its outlook improve. No resistance remains due to overhead supply. The prior gain and strong close above the pivot point clinched a technical buy signal.<br><hr>6/24/2022 12:21:17 PM - Y - No resistance remains due to overhead supply as it gapped up today and hit a new high with its 5th consecutive gain backed by above average volume. Rebound above the 50 DMA line ($298) helped its outlook improve. A gain and strong close above the pivot point backed by at least +40% above average volume may clinch a technical buy signal.<br><hr>6/23/2022 10:26:56 PM - Y - Today marked a 4th consecutive gain with above average volume as it challenged the prior high closes. Rebound above the 50 DMA line ($297.63) helped its outlook improve. Little resistance remains due to overhead supply.<br><hr>6/23/2022 2:02:28 PM - Y - On track today for a 4th consecutive gain. Rebound above the 50 DMA line ($297.58) helped its outlook improve. Little resistance remains due to overhead supply. <b>Keep in mind that the fact-based investment system discourages new buying in any stocks until a solid follow-through day confirms a new market uptrend (M criteria).</b><br><hr>6/22/2022 12:46:27 PM - Y - Color code is changed to yellow after rebounding above the 50 DMA line ($297.54) helping its outlook improve. Little resistance remains due to overhead supply. <b>Keep in mind that the fact-based investment system discourages new buying in any stocks until a solid follow-through day confirms a new market uptrend (M criteria).</b><br><hr>6/21/2022 6:21:08 PM - G - Posted a gain today with below average volume rebounding near its 50 DMA line ($297.65) which is now downward sloping and may act as resistance. A rebound above the 50 DMA line is needed for its outlook to improve. The fact-based investment system discourages any new buying until a follow-through day confirms a new market uptrend (M criteria).<br><hr>6/17/2022 12:31:37 PM - G - Quietly slumped below its 50 DMA line ($298) which may now act as resistance. A rebound above the 50 DMA line is needed for its outlook to improve. The fact-based investment system discourages any new buying until a follow-through day confirms a new market uptrend (M criteria).<br><hr>6/16/2022 5:16:09 PM - G - Small loss today came with below average volume while slumping further below its 50 DMA line ($298). A rebound above the 50 DMA line is needed for its outlook to improve. The fact-based investment system discourages any new buying until a follow-through day confirms a new market uptrend (M criteria).<br><hr>6/14/2022 5:13:04 PM - G - Suffered a 4th consecutive loss today with below average volume while slumping further below its 50 DMA line ($298). A rebound above the 50 DMA line is needed for its outlook to improve. Subsequent gains above the pivot point backed by at least +40% above average volume may help clinch a convincing technical buy signal. Fundamentals remain strong.<br><hr>6/13/2022 5:16:08 PM - G - Gapped down today for a loss with near average volume while slumping further below its 50 DMA line ($298). A rebound above the 50 DMA line is needed for its outlook to improve. Subsequent gains above the pivot point backed by at least +40% above average volume may help clinch a convincing technical buy signal. Fundamentals remain strong.<br><hr>6/10/2022 4:08:59 PM - G - Pulled back with light volume today undercutting its 50 DMA line ($298) and prior low raising concerns and its color code is changed to green. A rebound above the 50 DMA line is needed for its outlook to improve. Subsequent gains above the pivot point backed by at least +40% above average volume may help clinch a convincing technical buy signal. Fundamentals remain strong.<br><hr>6/9/2022 5:45:35 PM - Y - Pulled back with light volume today slumping toward its 50 DMA line ($298) and prior low defining important near-term support. Pivot point cited was based on its 4/07/22 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may help clinch a convincing technical buy signal. Fundamentals remain strong.<br><hr>6/7/2022 5:23:14 PM - Y - Posted a 2nd consecutive volume-driven gain today. Pulled back last week from a new high yet found support above its 50 DMA line ($297). Pivot point cited was based on its 4/07/22 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may help clinch a convincing technical buy signal. Fundamentals remain strong. See the latest FSU analysis for more details and an annotated graph.<br><hr>6/6/2022 5:12:58 PM - Y - Consolidating above its 50 DMA line ($297) which defines important near-term support to watch. Pivot point cited was based on its 4/07/22 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may help clinch a convincing technical buy signal. Fundamentals remain strong. See the latest FSU analysis for more details and a new annotated graph.<br><hr>6/6/2022 12:48:22 PM - Y - Consolidating above its 50 DMA line ($297) which defines important near-term support to watch. Pivot point cited was based on its 4/07/22 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may help clinch a convincing technical buy signal. Fundamentals remain strong.<br><hr>6/3/2022 5:18:39 PM - Y - Pulled back with lighter than average volume today for a 4th consecutive loss. Its 50 DMA line ($296.52) defines important near-term support to watch. Pivot point cited was based on its 4/07/22 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may trigger a convincing technical buy signal. Fundamentals remain strong.<br><hr>6/2/2022 6:00:25 PM - Y - Pulled back with above average volume today for a 3rd consecutive loss. Its 50 DMA line ($296) recently acted as support. Pivot point cited was based on its 4/07/22 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may trigger a convincing technical buy signal. Fundamentals remain strong.<br><hr>6/1/2022 6:30:45 PM - Y - Pulled back with lighter volume today. Its 50 DMA line ($296) recently acted as support. Pivot point cited was based on its 4/07/22 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may trigger a convincing technical buy signal. Fundamentals remain strong.<br><hr>5/31/2022 4:56:44 PM - Y - Pulled back today with heavy volume, retreating from a new 52-week high following 6 consecutive gains backed by lackluster volume. Its 50 DMA line ($295) recently acted as support. Pivot point cited was based on its 4/07/22 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may trigger a convincing technical buy signal. Fundamentals remain strong.<br><hr>5/27/2022 6:02:11 PM - Y - Hit a new 52-week high with today's 6th consecutive gain backed by +25% above average volume. Its 50 DMA line ($294) recently acted as support. Pivot point cited was based on its 4/07/22 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may trigger a convincing technical buy signal. Fundamentals remain strong.<br><hr>5/26/2022 6:14:08 PM - Y - Managed a new high close and challenged its 52-week high with today's 5th consecutive gain with near average volume. Its 50 DMA line ($294) recently acted as support. Pivot point cited was based on its 4/07/22 high plus 10 cents. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria).<br><hr>5/25/2022 4:42:53 PM - Y - Perched within close striking distance of its 52-week high after a 4th consecutive small gain with near average volume. Near its 50 DMA line ($293) it recently found prompt support. Pivot point cited was based on its 4/07/22 high plus 10 cents. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria).<br><hr>5/24/2022 5:37:14 PM - Y - Posted a 3rd consecutive small gain with near average volume, consolidating above its 50 DMA line ($292.74) which recently acted as support. Perched within close striking distance of its 52-week high. Pivot point cited was based on its 4/07/22 high plus 10 cents. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria).<br><hr>5/23/2022 5:14:56 PM - Y - Consolidating above its 50 DMA line ($292) which recently acted as support. Perched within striking distance of its 52-week high and its color code was changed to yellow. Pivot point cited was based on its 4/07/22 high plus 10 cents. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria).<br><hr>5/20/2022 4:54:57 PM - Y - Color code is changed to yellow after rebounding above its 50 DMA line ($291) helping its outlook improve. Perched within striking distance of its 52-week high and its color code is changed to yellow. Pivot point cited was based on its 4/07/22 high plus 10 cents. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria).<br><hr>5/19/2022 4:54:30 PM - G - Slumping after challenging its 52-week high, violating its 50 DMA line ($290.62) with a loss on higher volume today triggering a technical sell signal and its color code is changed to green. Only a prompt rebound above the 50 DMA line would help its outlook improve. Highlighted in yellow in the 5/16/222 mid-day report with pivot point cited based on its 4/07/22 high plus 10 cents. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria).<br><hr>5/16/2022 5:10:17 PM - Y - Challenged its 52-week high today but finished near the middle of its intra-day range after highlighted in yellow in the earlier mid-day report with pivot point cited based on its 4/07/22 high plus 10 cents. Found support near prior highs and its 50 DMA line ($289) during a 6-week consolidation. Reported Mar &#39;22 quarterly earnings +63% on +15% sales revenues versus the year ago period. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). See the latest FSU analysis for more details and a new annotated graph.<br><hr>5/16/2022 12:28:28 PM - Y - Color code is changed to yellow with pivot point cited based on its 4/07/22 high plus 10 cents. Challenging its 52-week high with today&#39;s gain. Found support near prior highs and its 50 DMA line ($289) during a 6-week consolidation. Reported Mar &#39;22 quarterly earnings +63% on +15% sales revenues versus the year ago period. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria).<br><hr>4/28/2022 12:47:11 PM - Reported Mar &#39;22 quarterly earnings +63% on +15% sales revenues versus the year ago period. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Recently finding support near prior highs and its 50 DMA line ($278) but it has not formed a new base of sufficient length.<br><hr>4/6/2022 12:16:05 PM - Reported Dec &#39;21 quarterly earnings +8% on +8% sales revenues versus the year ago period, below the +25% minimum earnings guideline (C criteria). Found support near its 200 DMA line then rebounded impressively to hit new highs since last noted on 1/24/22 when dropped from the Featured Stocks list.<br><hr>1/24/2022 5:47:09 PM - Undercut its prior low and tested its 200 DMA line ($236.91) with today's 4th consecutive loss raising concerns and triggering technical sell signals. A rebound above the 50 DMA line ($258) is needed for its outlook to improve. It will be dropped from the Featured Stocks list tonight.<br><hr>1/18/2022 5:06:24 PM - G - Posted a gain today with lighter volume, halting its slide after slumping well below its 50 DMA line ($260) with recent volume-driven losses raising concerns and triggering a technical sell signal. A prompt rebound above the 50 DMA line is needed for its outlook to improve. See the latest FSU analysis for more details and a new annotated graph.<br><hr>1/12/2022 12:50:12 PM - G - Color code is changed to green after slumping well below its 50 DMA line ($261) with today&#39;s big volume-driven loss raising greater concerns and triggering a technical sell signal. A prompt rebound above the 50 DMA line is needed for its outlook to improve.<br><hr>1/11/2022 5:44:23 PM - Y - Still consolidating near its 50 DMA line ($260.90) with volume totals cooling.  More damaging losses would raise greater concerns and trigger a technical sell signal.<br><hr>1/5/2022 8:26:21 PM - Y - Suffered a 5th consecutive loss today testing the recent low ($260) and its 50 DMA line ($260.21).  More damaging losses would raise greater concerns and trigger a technical sell signal.<br><hr>12/29/2021 3:58:53 PM - Y - Showed resilience after a pullback and volume totals have been cooling while it remains perched near its all-time high. Recent low ($260) defines initial support to watch above its 50 DMA line ($257.49)<br><hr>12/23/2021 5:35:38 PM - Y - Posted a quiet 3rd consecutive gain today, closing the week perched near its all-time high. Finished strong after highlighted in yellow in the 12/16/21 mid-day report with pivot point cited based on its 8/17/21 high plus 10 cents. This giant Medical - Diversified firm triggered a technical buy signal as it powered to new all-time highs with +78% above average volume behind its 5th consecutive gain after a choppy 17-week consolidation. Reported Sep &#39;21 quarterly earnings +38% on +18% sales revenues versus the year ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>12/21/2021 6:07:42 PM - Y - Posted a quiet gain today after retreating from its all-time high. Finished strong after highlighted in yellow in the 12/16/21 mid-day report with pivot point cited based on its 8/17/21 high plus 10 cents. This giant Medical - Diversified firm triggered a technical buy signal as it powered to new all-time highs with +78% above average volume behind its 5th consecutive gain after a choppy 17-week consolidation. Reported Sep &#39;21 quarterly earnings +38% on +18% sales revenues versus the year ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>12/17/2021 1:02:38 PM - Y - Retreating from its all-time high with today&#39;s loss after a streak of gains. Finished strong after highlighted in yellow in the prior mid-day report with pivot point cited based on its 8/17/21 high plus 10 cents. This giant Medical - Diversified firm triggered a technical buy signal as it powered to new all-time highs with +78% above average volume behind its 5th consecutive gain after a choppy 17-week consolidation. Reported Sep &#39;21 quarterly earnings +38% on +18% sales revenues versus the year ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14. See the latest FSU analysis for more details and an annotated graph.<br><hr>12/16/2021 5:31:49 PM - Y - Finished strong today after highlighted in yellow in the earlier mid-day report with pivot point cited based on its 8/17/21 high plus 10 cents. This giant Medical - Diversified firm triggered a technical buy signal as it powered to new all-time highs with +78% above average volume behind its 5th consecutive gain after a choppy 17-week consolidation. Reported Sep &#39;21 quarterly earnings +38% on +18% sales revenues versus the year ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14. See the latest FSU analysis for more details and a new annotated graph.<br><hr>12/16/2021 1:11:20 PM - Y - Color code is changed to yellow with pivot point cited based on its 8/17/21 high plus 10 cents. This giant Medical - Diversified firm is powering to new all-time highs with today&#39;s 5th consecutive gain after a choppy 17-week consolidation. Reported Sep &#39;21 quarterly earnings +38% on +18% sales revenues versus the year ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>12/15/2021 12:40:23 PM - Challenging its all-time high after a choppy 17-week consolidation with today&#39;s big volume-driven gain after briefly sputtering below its 50 DMA line ($250). Reported Sep &#39;21 quarterly earnings +38% on +18% sales revenues versus the year ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>11/30/2021 12:13:59 PM - Met resistance recently near the prior high $275) and it is encountering distributional pressure this week testing its 50 DMA line ($246). Reported Sep &#39;21 quarterly earnings +38% on +18% sales revenues versus the year ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>11/17/2021 12:49:42 PM - Perched within striking distance of its all-time high after forming a 13-week cup-with-handle base while recently consolidating well above its 200 DMA line. Reported Sep &#39;21 quarterly earnings +38% on +18% sales revenues versus the year ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>10/26/2021 12:32:52 PM - Consolidating near its 50 DMA line after finding support well above its 200 DMA line. Reported Sep &#39;21 quarterly earnings +38% on +18% sales revenues versus the year ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>9/10/2021 12:57:12 PM - Violated its 50 DMA line ($251) with a big volume-driven loss raising concerns as the prior mid-day report cautioned members - <i>&quot;Reported Jun &#39;21 quarterly earnings +29% on +23% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.&quot;</i><br><hr>9/9/2021 1:02:21 PM - Violating its 50 DMA line ($251) with today&#39;s big loss raising concerns. Reported Jun &#39;21 quarterly earnings +29% on +23% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>6/11/2021 12:42:02 PM - Powered to new all-time highs with volume-driven gains this week. Reported Mar &#39;21 quarterly earnings +16% on +16% sales revenues versus the year ago period/ Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>6/17/2020 12:52:37 PM - Gapped up on the prior session hitting a new all-time high. Reported Mar &#39;20 quarterly earnings +32% on +15% sales revenues versus the year ago period, its 2nd strong quarter. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>3/20/2020 12:55:43 PM - Retreated below its 50 DMA line with volume-driven losses.  Recent sessions have been marked by wider than usual intra-day swings indicative of uncertainty. Reported Dec &#39;19 quarterly earnings +31% on +8% sales revenues, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>3/16/2020 12:40:14 PM - Reported Dec &#39;19 quarterly earnings +31% on +8% sales revenues, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>3/13/2020 12:29:36 PM - Reported Dec &#39;19 quarterly earnings +31% on +8% sales revenues, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>3/6/2020 12:19:59 PM - Perched near its all-time high after rebounding from an abrupt retreat near its 200 DMA line last week. Reported Dec &#39;19 quarterly earnings +31% on +8% sales revenues, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>2/10/2020 12:46:17 PM - Perched near its all-time high and extended from any sound base. Reported Dec &#39;19 quarterly earnings +31% on +8% sales revenues, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) improved steadily since a downturn in FY &#39;14.<br><hr>3/13/2019 12:28:44 PM - Encountering distributional pressure and pulling back from its all-time high after today&#39;s early gain. The 3/11/19 mid-day report noted - <i>&quot;Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.&quot;</i><br><hr>3/11/2019 12:19:52 PM - Encountering distributional pressure and pulling back from its all-time high after an impressive streak of volume-driven gains. Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>3/8/2019 12:08:32 PM - Encountering distributional pressure this week while perched at its all-time high after an impressive streak of volume-driven gains. Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>3/7/2019 12:41:36 PM - Encountering distributional pressure this week while perched at its all-time high after an impressive streak of volume-driven gains. Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>3/6/2019 12:22:29 PM - Hovering near its all-time high after an impressive streak of volume-driven gains. Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>2/28/2019 12:48:33 PM - Hitting new 52-week and all-time highs with yet another volume-driven gain today, adding to a recent spurt. Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>2/27/2019 1:12:26 PM - Hitting new 52-week and all-time highs with yet another volume-driven gain today, adding to a recent spurt. Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>2/26/2019 12:25:59 PM - Hitting new 52-week and all-time highs with another volume-driven gain today, adding to a recent spurt. Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>2/22/2019 12:43:23 PM - Hitting new 52-week and all-time highs with another volume-driven gain today, adding to a recent spurt. Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>2/6/2019 12:47:07 PM - Perched at its 52-week high. Reported Dec &#39;18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>1/18/2019 12:26:47 PM - Rebounded above its 50 DMA line and challenged its 52-week high on the prior session. Reported Sep &#39;18 quarterly earnings +32% on +7% sales revenues, marking its 3rd consecutive earnings increase above the +25% minimum guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>12/20/2018 12:48:31 PM - After damaging volume-driven losses violated its 50 DMA line ($111.68) that important short-term average may now act as resistance. Reported Sep &#39;18 quarterly earnings +32% on +7% sales revenues, marking its 3rd consecutive earnings increase above the +25% minimum guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>12/19/2018 12:24:03 PM - Rebounding today after damaging volume-driven losses violated its 50 DMA line ($111.84) again. Reported Sep &#39;18 quarterly earnings +32% on +7% sales revenues, marking its 3rd consecutive earnings increase above the +25% minimum guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>11/6/2018 12:34:42 PM - Gapped down today and it is undercutting its 50 DMA line ($108) again while retreating from its all-time high. Reported Sep &#39;18 quarterly earnings +32% on +7% sales revenues, marking its 3rd consecutive earnings increase above the +25% minimum guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>11/5/2018 12:53:44 PM - Gapped up today. Found support near its 50 DMA line while consolidating from its all-time high. Due to report Sep &#39;18 quarterly results, and volume and volatility often increase near earnings news. Showed earnings increases above the +25% minimum guideline (C criteria) in the Mar and Jun &#39;18 quarterly comparisons versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>10/8/2018 12:46:29 PM - Hitting yet another new all-time highs with a streak of 10 consecutive gains. Showed earnings increases above the +25% minimum guideline (C criteria) in the Mar and Jun &#39;18 quarterly comparisons versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>10/5/2018 12:44:16 PM - Gapped up again today hitting new all-time highs with 9 consecutive gains. Showed earnings increases above the +25% minimum guideline (C criteria) in the Mar and Jun &#39;18 quarterly comparisons versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>10/4/2018 12:39:26 PM - Gapped up today and hit a new all-time high with its 8th consecutive gain. Showed earnings increases above the +25% minimum guideline (C criteria) in the Mar and Jun &#39;18 quarterly comparisons versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY &#39;14.<br><hr>